US 12281136
Crystalline forms of a CD73 inhibitor and uses thereof
granted A61KA61K31/706A61K45/06
Quick answer
US patent 12281136 (Crystalline forms of a CD73 inhibitor and uses thereof) held by Arcus Biosciences, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/706, A61K45/06, A61P, A61P35/00